Silverarc Capital Management »

Celldex Therapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 375k 37.01
2024-03-31 $13M 299k 41.97
2023-12-31 $9.8M 247k 39.66
2023-06-30 $339k 10k 33.93
2023-03-31 $3.0M 85k 35.98
2022-12-31 $2.4M 55k 44.57
2022-09-30 $1.5M 53k 28.12
2022-06-30 $2.0M 72k 26.97
2022-03-31 $256k 46k 5.62
2021-12-31 $1.7M 45k 38.64
2021-09-30 $2.1M 38k 54.00
2021-06-30 $2.9M 9.9k 294.93
2020-12-31 $1.4M 80k 17.53